A Phase 1/2 Study Evaluating the Safety and Efficacy of ABT 751 in Combination With Pemetrexed Versus Pemetrexed Alone in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer
Phase of Trial: Phase I/II
Latest Information Update: 07 Feb 2013
At a glance
- Drugs ABT 751 (Primary) ; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 07 Feb 2013 Last checked against ClinicalTrials.gov record.
- 08 Nov 2010 Actual end date (January 2009) added as reported by ClinicalTrials.gov.
- 04 Mar 2009 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History